Lista de obras - Bertrand Tombal - Dominio Público Uruguay

A holistic approach to androgen deprivation therapy: treating the cancer without hurting the patient.

artículo científico publicado en 2009

A multi-institutional analysis comparing adjuvant and salvage radiation therapy for high-risk prostate cancer patients with undetectable PSA after prostatectomy

scientific article published on 13 October 2010

A phase III extension trial with a 1-arm crossover from leuprolide to degarelix: comparison of gonadotropin-releasing hormone agonist and antagonist effect on prostate cancer.

artículo científico publicado en 2011

Access to information and expectations of treatment decisions for prostate cancer patients--results of a European survey

scientific article published on 16 January 2013

Additional analysis of the secondary end point of biochemical recurrence rate in a phase 3 trial (CS21) comparing degarelix 80 mg versus leuprolide in prostate cancer patients segmented by baseline characteristics.

artículo científico publicado en 2009

Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy

artículo científico publicado en 2015

Assessing the risk of unsuspected prostate cancer in patients with benign prostatic hypertrophy: a 13-year retrospective study of the incidence and natural history of T1a-T1b prostate cancers.

artículo científico publicado en 1999

Assessment and validation of a microinjection method for kinetic analysis of [Ca2+]i in individual cells undergoing apoptosis

scientific article published on 01 January 1999

Assessment of the transcriptional activity of p53 improves the prediction of recurrence in superficial transitional cell carcinoma of the bladder

artículo científico publicado en 2005

Biopsy and treatment decisions in the initial management of prostate cancer and the role of PCA3; a systematic analysis of expert opinion

artículo científico publicado en 2011

Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?

artículo científico publicado en 2012

Cardiovascular risk during hormonal treatment in patients with prostate cancer ⬇️

artículo científico publicado el 2 de marzo de 2011

Castration-resistant prostate cancer: from new pathophysiology to new treatment targets.

artículo científico publicado en 2009

Chairperson's introduction: Prostate cancer (PCa) is the most frequently detected cancer in the European Union in men above 50 years of age

artículo científico publicado en 2011

Changes in alkaline phosphatase levels in patients with prostate cancer receiving degarelix or leuprolide: results from a 12-month, comparative, phase III study.

artículo científico publicado en 2009

Characterization and multiparameter analysis of visual adverse events in irofulven single-agent phase I and II trials.

artículo científico publicado en 2004

Chemoprevention of prostate cancer with nutrients and supplements.

artículo científico publicado en 2011

Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.

artículo científico

Contemporary role of salvage lymphadenectomy in patients with recurrence following radical prostatectomy

artículo científico

Continuous Improvement Versus Innovation: The Case for Sipuleucel-T ⬇️

artículo científico publicado el 30 de noviembre de 2011

Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-2

artículo científico publicado en 2020

Defining the Most Informative Intermediate Clinical Endpoints for Predicting Overall Survival in Patients Treated with Radical Prostatectomy for High-risk Prostate Cancer

scientific article published on 24 December 2018

Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial ⬇️

artículo científico publicado el 15 de noviembre de 2011

Do intraoperative analgesics influence oncological outcomes after radical prostatectomy for prostate cancer?

artículo científico publicado en 2011

Docetaxel and beyond

artículo científico publicado en 2007

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees

scientific article published on 19 November 2019

Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis

scientific article published on 16 May 2012

Editorial comment on: Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth

artículo científico publicado en 2008

Educational tool-kit on diet and exercise: survey of prostate cancer patients about to receive androgen deprivation therapy

artículo científico publicado en 2010

Evaluation of DCE-MRI postprocessing techniques to assess metastatic bone marrow in patients with prostate cancer ⬇️

artículo científico publicado el 8 de junio de 2012

Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation

scientific article published on 18 June 2020

Expert opinion on 6-monthly luteinizing hormone-releasing hormone agonist treatment with the single-sphere depot system for prostate cancer.

artículo científico publicado en 2007

Focal therapy in prostate cancer-report from a consensus panel.

artículo científico publicado en 2010

Free to total prostate-specific antigen (PSA) ratio improves the discrimination between prostate cancer and benign prostatic hyperplasia (BPH) in the diagnostic gray zone of 1.8 to 10 ng/mL total PSA

artículo científico publicado en 1996

Free/total PSA ratio does not improve prediction of pathologic stage and biochemical recurrence after radical prostatectomy

artículo científico publicado en 2002

Hormone Therapy for Prostate Cancer: What Have We Done With Charles Huggins’ Legacy? ⬇️

artículo científico publicado el 15 de septiembre de 2011

Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer

artículo científico publicado en 2011

Impact of Lymph Node Burden on Survival of High-risk Prostate Cancer Patients Following Radical Prostatectomy and Pelvic Lymph Node Dissection

artículo científico publicado en 2016

Impact of primary tumor location on survival from EORTC advanced urothelial cancer studies.

artículo científico publicado en 2017

Inhibition of caspase activity does not prevent the signaling phase of apoptosis in prostate cancer cells

artículo científico publicado en 1999

Intermittent androgen deprivation therapy: conventional wisdom versus evidence

artículo científico publicado en 2009

Is there a prostate-specific antigen upper limit for radical prostatectomy?

artículo científico publicado en 2011

Long-term Impact of Adjuvant Versus Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Patients Treated with Radical Prostatectomy: Results from a Multi-institutional Series

artículo científico publicado en 2016

METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer.

artículo científico publicado en 2016

Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting

scientific article published on 21 December 2010

Magnetic resonance imaging of the axial skeleton enables objective measurement of tumor response on prostate cancer bone metastases

artículo científico publicado en 2005

Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies.

artículo científico publicado en 2007

Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019

artículo científico publicado en 2020

Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.

artículo científico publicado en 2017

Management of advanced prostate cancer: can we improve on androgen deprivation therapy?

artículo científico publicado en 2008

Maximizing outcomes in genitourinary cancers across the treatment continuum ⬇️

artículo científico publicado el 1 de abril de 2011

Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer

artículo científico

Modern Detection of Prostate Cancer's Bone Metastasis: Is the Bone Scan Era Over?

artículo científico publicado en 2011

New treatment paradigm for prostate cancer: abarelix initiation therapy for immediate testosterone suppression followed by a luteinizing hormone-releasing hormone agonist

artículo científico publicado en 2012

Non-metastatic CRPC and asymptomatic metastatic CRPC: which treatment for which patient?

artículo científico publicado en 2012

Open to debate. The motion: Hormonal blockade should be limited due to significant adverse effects

scientific article published on 14 October 2008

Outcome predictors of radical prostatectomy in patients with prostate-specific antigen greater than 20 ng/ml: a European multi-institutional study of 712 patients

artículo científico publicado en 2010

Patterns and predictors of early biochemical recurrence after radical prostatectomy and adjuvant radiation therapy in men with pT3N0 prostate cancer: implications for multimodal therapies

artículo científico publicado en 2013

Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)

scientific article published on 19 October 2012

Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy.

artículo científico publicado en 2013

Pretreatment tables predicting pathologic stage of locally advanced prostate cancer

artículo científico publicado en 2014

Prognostic relevance of number and bilaterality of positive surgical margins after radical prostatectomy

artículo científico publicado en 2011

Prognostic value of circulating prostate cells in patients with a rising PSA after radical prostatectomy.

artículo científico publicado en 2003

Prospective comparison of a fast 1.5-T biparametric with the 3.0-T multiparametric ESUR magnetic resonance imaging protocol as a triage test for men at risk of prostate cancer

scientific article published on 19 October 2018

Prospective randomized evaluation of emergency extracorporeal shock wave lithotripsy (ESWL) on the short-time outcome of symptomatic ureteral stones.

artículo científico publicado en 2005

Prospective randomized study comparing docetaxel, estramustine, and prednisone with docetaxel and prednisone in metastatic hormone-refractory prostate cancer.

artículo científico publicado en 2008

Prostate cancer screening: clinical impact of WHO calibration of Beckman Coulter Access prostate-specific antigen assays

scientific article published on 01 February 2010

Prostate cancer: Bone Scan Index made easy, at last

artículo científico publicado en 2012

Rapid in situ hybridization technique for detecting malignant mouse cell contamination in human xenograft tissue from nude mice and in vitro cultures from such xenografts

artículo científico publicado en 1999

Rationale for Modernising Imaging in Advanced Prostate Cancer.

artículo científico publicado en 2016

Role of store-dependent influx of Ca2+ and efflux of K+ in apoptosis of CHO cells.

artículo científico publicado en 2004

Stratification of high-risk prostate cancer into prognostic categories: a European multi-institutional study

artículo científico publicado en 2014

Testosterone in prostate cancer: the Bethesda consensus ⬇️

artículo científico publicado el 30 de noviembre de 2011

Thapsigargin analogues for targeting programmed death of androgen-independent prostate cancer cells

artículo científico publicado en 1999

Thapsigargin induces a calmodulin/calcineurin-dependent apoptotic cascade responsible for the death of prostatic cancer cells.

artículo científico publicado en 2000

The role of abiraterone acetate in the management of prostate cancer: a critical analysis of the literature.

artículo científico publicado en 2011

The role of adjuvant hormonal treatment after surgery for localized high-risk prostate cancer: results of a matched multiinstitutional analysis

artículo científico publicado en 2012

Toward the End of Blind Prostate Biopsies? ⬇️

artículo científico publicado el 2 de agosto de 2012

What is the pathophysiology of a hormone-resistant prostate tumour?

artículo científico publicado en 2011

Whole-body MRI (WB-MRI) versus axial skeleton MRI (AS-MRI) to detect and measure bone metastases in prostate cancer (PCa)

artículo científico publicado en 2010

Words of Wisdom. Re: pharmacological prevention of side effects of androgen deprivation therapy, a new challenge?

artículo científico publicado en 2011

Words of wisdom: Re: Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial

artículo científico publicado en 2012

[Contribution of the preoperative urodynamic findings in the determination of risks factors of urinary incontinence after radical retropubic prostatectomy]

artículo científico publicado en 2003

[Fournier's gangrene on ischial pressure ulcer: use of vacuum-assisted closure and therapeutic strategy]

artículo científico publicado en 2007

[Innovations in hormonal treatment for locally advanced and/or metastatic prostate cancer]

artículo científico publicado en 2011

[Non continent urinary transcutaneous derivation to cure recurrent vesicostomy prolapse]

artículo científico publicado en 2009

Lista de obras de Bertrand Tombal

A holistic approach to androgen deprivation therapy: treating the cancer without hurting the patient.

A multi-institutional analysis comparing adjuvant and salvage radiation therapy for high-risk prostate cancer patients with undetectable PSA after prostatectomy

A phase III extension trial with a 1-arm crossover from leuprolide to degarelix: comparison of gonadotropin-releasing hormone agonist and antagonist effect on prostate cancer.

Access to information and expectations of treatment decisions for prostate cancer patients--results of a European survey

Additional analysis of the secondary end point of biochemical recurrence rate in a phase 3 trial (CS21) comparing degarelix 80 mg versus leuprolide in prostate cancer patients segmented by baseline characteristics.

Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy

Assessing the risk of unsuspected prostate cancer in patients with benign prostatic hypertrophy: a 13-year retrospective study of the incidence and natural history of T1a-T1b prostate cancers.

Assessment and validation of a microinjection method for kinetic analysis of [Ca2+]i in individual cells undergoing apoptosis

Assessment of the transcriptional activity of p53 improves the prediction of recurrence in superficial transitional cell carcinoma of the bladder

Biopsy and treatment decisions in the initial management of prostate cancer and the role of PCA3; a systematic analysis of expert opinion

Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?

Cardiovascular risk during hormonal treatment in patients with prostate cancer ⬇️

Castration-resistant prostate cancer: from new pathophysiology to new treatment targets.

Chairperson's introduction: Prostate cancer (PCa) is the most frequently detected cancer in the European Union in men above 50 years of age

Changes in alkaline phosphatase levels in patients with prostate cancer receiving degarelix or leuprolide: results from a 12-month, comparative, phase III study.

Characterization and multiparameter analysis of visual adverse events in irofulven single-agent phase I and II trials.

Chemoprevention of prostate cancer with nutrients and supplements.

Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.

Contemporary role of salvage lymphadenectomy in patients with recurrence following radical prostatectomy

Continuous Improvement Versus Innovation: The Case for Sipuleucel-T ⬇️

Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-2

Defining the Most Informative Intermediate Clinical Endpoints for Predicting Overall Survival in Patients Treated with Radical Prostatectomy for High-risk Prostate Cancer

Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial ⬇️

Do intraoperative analgesics influence oncological outcomes after radical prostatectomy for prostate cancer?

Docetaxel and beyond

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees

Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis

Editorial comment on: Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth

Educational tool-kit on diet and exercise: survey of prostate cancer patients about to receive androgen deprivation therapy

Evaluation of DCE-MRI postprocessing techniques to assess metastatic bone marrow in patients with prostate cancer ⬇️

Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation

Expert opinion on 6-monthly luteinizing hormone-releasing hormone agonist treatment with the single-sphere depot system for prostate cancer.

Focal therapy in prostate cancer-report from a consensus panel.

Free to total prostate-specific antigen (PSA) ratio improves the discrimination between prostate cancer and benign prostatic hyperplasia (BPH) in the diagnostic gray zone of 1.8 to 10 ng/mL total PSA

Free/total PSA ratio does not improve prediction of pathologic stage and biochemical recurrence after radical prostatectomy

Hormone Therapy for Prostate Cancer: What Have We Done With Charles Huggins’ Legacy? ⬇️

Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer

Impact of Lymph Node Burden on Survival of High-risk Prostate Cancer Patients Following Radical Prostatectomy and Pelvic Lymph Node Dissection

Impact of primary tumor location on survival from EORTC advanced urothelial cancer studies.

Inhibition of caspase activity does not prevent the signaling phase of apoptosis in prostate cancer cells

Intermittent androgen deprivation therapy: conventional wisdom versus evidence

Is there a prostate-specific antigen upper limit for radical prostatectomy?

Long-term Impact of Adjuvant Versus Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Patients Treated with Radical Prostatectomy: Results from a Multi-institutional Series

METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer.

Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting

Magnetic resonance imaging of the axial skeleton enables objective measurement of tumor response on prostate cancer bone metastases

Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies.

Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019

Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.

Management of advanced prostate cancer: can we improve on androgen deprivation therapy?

Maximizing outcomes in genitourinary cancers across the treatment continuum ⬇️

Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer

Modern Detection of Prostate Cancer's Bone Metastasis: Is the Bone Scan Era Over?

New treatment paradigm for prostate cancer: abarelix initiation therapy for immediate testosterone suppression followed by a luteinizing hormone-releasing hormone agonist

Non-metastatic CRPC and asymptomatic metastatic CRPC: which treatment for which patient?

Open to debate. The motion: Hormonal blockade should be limited due to significant adverse effects

Outcome predictors of radical prostatectomy in patients with prostate-specific antigen greater than 20 ng/ml: a European multi-institutional study of 712 patients

Patterns and predictors of early biochemical recurrence after radical prostatectomy and adjuvant radiation therapy in men with pT3N0 prostate cancer: implications for multimodal therapies

Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)

Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy.

Pretreatment tables predicting pathologic stage of locally advanced prostate cancer

Prognostic relevance of number and bilaterality of positive surgical margins after radical prostatectomy

Prognostic value of circulating prostate cells in patients with a rising PSA after radical prostatectomy.

Prospective comparison of a fast 1.5-T biparametric with the 3.0-T multiparametric ESUR magnetic resonance imaging protocol as a triage test for men at risk of prostate cancer

Prospective randomized evaluation of emergency extracorporeal shock wave lithotripsy (ESWL) on the short-time outcome of symptomatic ureteral stones.

Prospective randomized study comparing docetaxel, estramustine, and prednisone with docetaxel and prednisone in metastatic hormone-refractory prostate cancer.

Prostate cancer screening: clinical impact of WHO calibration of Beckman Coulter Access prostate-specific antigen assays

Prostate cancer: Bone Scan Index made easy, at last

Rapid in situ hybridization technique for detecting malignant mouse cell contamination in human xenograft tissue from nude mice and in vitro cultures from such xenografts

Rationale for Modernising Imaging in Advanced Prostate Cancer.

Role of store-dependent influx of Ca2+ and efflux of K+ in apoptosis of CHO cells.

Stratification of high-risk prostate cancer into prognostic categories: a European multi-institutional study

Testosterone in prostate cancer: the Bethesda consensus ⬇️

Thapsigargin analogues for targeting programmed death of androgen-independent prostate cancer cells

Thapsigargin induces a calmodulin/calcineurin-dependent apoptotic cascade responsible for the death of prostatic cancer cells.

The role of abiraterone acetate in the management of prostate cancer: a critical analysis of the literature.

The role of adjuvant hormonal treatment after surgery for localized high-risk prostate cancer: results of a matched multiinstitutional analysis

Toward the End of Blind Prostate Biopsies? ⬇️

What is the pathophysiology of a hormone-resistant prostate tumour?